Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement (ABOGRAFT trial)
2021-001708-14Phase 2Active
- Sponsor
- Region Östergötland
- Start
- May 2021
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vancomycin and tobramycin in periprosthetic joint infection (PJI) and surgical site infection (SSI) (2 arms), sponsored by Region Östergötland. Started May 2021; status: active.
02
Drugs
vancomycintobramycin
03
Conditions
periprosthetic joint infection (PJI)surgical site infection (SSI)
Beyond the preview
Go deeper on 2021-001708-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001708-14.